LNSR Q4 2021 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$11M+35.5% YoY

Gross Profit

$6M50.2% margin

Operating Income

-$4M-34.9% margin

Net Income

-$4M-34.8% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

+35.7%

Cash Flow

Operating Cash Flow

-$739,000

Free Cash Flow

-$895,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$66M

Total Liabilities

$12M

Stockholders' Equity

$55M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$8M	+35.5%
Gross Profit	$6M	$5M	+20.7%
Operating Income	-$4M	-$7M	+42.9%
Net Income	-$4M	-$7M	+42.9%

Revenue Segments

Product

$9M91%

Service

$844,0009%

Geographic Segments

UNITED STATES

$4M42%

Europe

$3M32%

Asia Excluding South Korea

$1M14%

KOREA, REPUBLIC OF

$1M10%

Other Geographical Region

$173,0002%